Smad4 and p53 synergize in suppressing autochthonous intestinal cancer
Sign Up to like & getrecommendations! Published in 2022 at "Cancer Medicine"
DOI: 10.1002/cam4.4533
Abstract: Smad4 and p53 mutations are the most common mutations in human colorectal cancers (CRCs). We evaluated whether and how they are synergistic in intestinal carcinogenesis using novel autochthonous mouse models. read more here.
Keywords: smad4 p53; synergize suppressing; p53 synergize; smad4 ... See more keywords